Diabetes & Metabolism Journal

Jinsoek Kim (Kim J)

1 Article

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity: Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Youngree Kim, Jinsoek Kim, Gwanpyo Koh, Daeho Lee; Diabetes Metab J. 2011;35(2):149-158. Published online April 30, 2011; DOI: https://doi.org/10.4093/dmj.2011.35.2.149

4,938 View
38 Download
28 Crossref

Background

Dipeptidyl peptidase 4 (DPP-4, also known as CD26) binds with adenosine deaminase (ADA) to activate T lymphocytes. Here, we investigated whether ADA activity is specifically affected by treatment with DPP-4 inhibitor (DPP4I) compared with other anti-diabetic agents.

Methods

Fasting ADA activity, in addition to various metabolic and biochemical parameters, were measured in 262 type 2 diabetes mellitus (T2DM) patients taking various anti-diabetic agents and in 46 non-diabetic control subjects.

Results

ADA activity was increased in T2DM patients compared with that in non-diabetic control subjects (mean±standard error, 23.1±0.6 U/L vs. 18.6±0.8 U/L; P<0.05). ADA activity was correlated with fasting plasma glucose (r=0.258, P<0.05), HbA1c (r=0.208, P<0.05), aspartate aminotransferase (r=0.325, P<0.05), and alanine aminotransferase (r=0.248, P<0.05). Compared with the well-controlled T2DM patients (HbA1c<7%), the poorly controlled group (HbA1c>9%) showed significantly increased ADA activity (21.1±0.8 U/L vs. 25.4±1.6 U/L; P<0.05). The effect of DPP4I on ADA activity in T2DM patients did not differ from those of other oral anti-diabetic agents or insulin. T2DM patients on metformin monotherapy showed a lower ADA activity (20.9±1.0 U/L vs. 28.1±2.8 U/L; P<0.05) compared with that of those on sulfonylurea monotherapy.

Conclusion

Our results show that ADA activity is increased in T2DM patients compared to that in non-diabetic patients, is positively correlated with blood glucose level, and that DPP4I has no additional specific effect on ADA activity, except for a glycemic control- or HbA1c-dependent effect.

Citations

Citations to this article as recorded by

Influence of BMI on adenosine deaminase and stroke outcomes in mechanical thrombectomy subjects
Benton Maglinger, Christopher J. McLouth, Jacqueline A. Frank, Chintan Rupareliya, Madison Sands, Lila Sheikhi, Shivani Pahwa, David Dornbos, Jordan P. Harp, Amanda L. Trout, Jadwiga Turchan-Cholewo, Ann M. Stowe, Justin F. Fraser, Keith R. Pennypacker
Brain, Behavior, & Immunity - Health.2022; 20: 100422. CrossRef
Glutamine restores testicular glutathione-dependent antioxidant defense and upregulates NO/cGMP signaling in sleep deprivation-induced reproductive dysfunction in rats
M.A. Hamed, T.M. Akhigbe, R.E. Akhigbe, A.O. Aremu, P.A. Oyedokun, J.A. Gbadamosi, P.E. Anifowose, M.A. Adewole, O.O. Aboyeji, H.O. Yisau, G.O. Tajudeen, M.M. Titiloye, N.F. Ayinla, A.F. Ajayi
Biomedicine & Pharmacotherapy.2022; 148: 112765. CrossRef
Effects of quercetin and metabolites on uric acid biosynthesis and consequences for gene expression in the endothelium
Sarka Tumova, Yuanlu Shi, Ian M. Carr, Gary Williamson
Free Radical Biology and Medicine.2021; 162: 191. CrossRef
The value of adenosine deaminase activity in latent autoimmune diabetes in adults and type 2 diabetes patients
Yu Zhou, Wei-Dong Jin, Zhen-Zhen Pang, Jun Xia, Su-Feng Chen
International Journal of Diabetes in Developing Countries.2021; 41(1): 48. CrossRef
Purinergic signaling in diabetes and metabolism
Shanu Jain, Kenneth A. Jacobson
Biochemical Pharmacology.2021; 187: 114393. CrossRef
Berberine modulates crucial erectogenic biomolecules and alters histological architecture in penile tissues of diabetic rats
Stephen Adeniyi Adefegha, Ganiyu Oboh, Felix Abayomi Dada, Sunday Idowu Oyeleye, Bathlomew Maduka Okeke
Andrologia.2021;[Epub] CrossRef
Suppression of uric acid and lactate production by sodium acetate ameliorates hepatic triglyceride accumulation in fructose-insulin resistant pregnant rats
Adewumi O. Oyabambi, Kehinde S. Olaniyi, Ayodele O. Soladoye, Lawrence A. Olatunji
Environmental Toxicology and Pharmacology.2020; 80: 103452. CrossRef
Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases
Barbara Kutryb-Zajac, Paulina Mierzejewska, Ewa M. Slominska, Ryszard T. Smolenski
Molecules.2020; 25(20): 4652. CrossRef
Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective
Trevor Simard, Richard Jung, Alisha Labinaz, Mohammad Ali Faraz, F. Daniel Ramirez, Pietro Di Santo, Ian Pitcher, Pouya Motazedian, Chantal Gaudet, Rebecca Rochman, Jeffrey Marbach, Paul Boland, Kiran Sarathy, Saleh Alghofaili, Juan J. Russo, Etienne Cout
Cardiovascular & Hematological Disorders-Drug Targets.2019; 19(2): 109. CrossRef
Mineralocorticoid receptor blockade attenuates disrupted glutathione-dependent antioxidant defense and elevated endoglin in the hearts of pregnant rats exposed to testosterone
Taofeek O. Usman, Olufunto O. Badmus, InKyeom Kim, Lawrence A. Olatunji
Naunyn-Schmiedeberg's Archives of Pharmacology.2019; 392(7): 773. CrossRef
Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity
Seda Kahraman, Alev Eroglu Altinova, Serenay Elgun, Mehmet Muhittin Yalcin, Banu Aktas Yilmaz, Cigdem Ozkan, Mujde Akturk, Fusun Balos Toruner
Gynecological Endocrinology.2019; 35(8): 714. CrossRef
Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants
Chao Xuan, Qing-Wu Tian, Shao-Yan Zhang, Hui Li, Ting-Ting Tian, Peng Zhao, Kang Yue, Yan-Yan Ling, Guo-Wei He, Li-Min Lun
Therapeutic Advances in Chronic Disease.2019;[Epub] CrossRef
Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism
Christopher Papandreou, Jun Li, Liming Liang, Mònica Bulló, Yan Zheng, Miguel Ruiz-Canela, Edward Yu, Marta Guasch-Ferré, Cristina Razquin, Clary Clish, Dolores Corella, Ramon Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Lluís Serra-Majem, Nuria R
Scientific Reports.2019;[Epub] CrossRef
Current status of G-protein coupled receptors as potential targets against type 2 diabetes mellitus
Mehboob Hoque, Safdar Ali, Muddasarul Hoda
International Journal of Biological Macromolecules.2018; 118: 2237. CrossRef
Endoglin inhibition by sodium acetate and flutamide ameliorates cardiac defective G6PD-dependent antioxidant defense in gestational testosterone-exposed rats
Lawrence A. Olatunji, Emmanuel D. Areola, Olufunto O. Badmus
Biomedicine & Pharmacotherapy.2018; 107: 1641. CrossRef
Sodium acetate and androgen receptor blockade improve gestational androgen excess-induced deteriorated glucose homeostasis and antioxidant defenses in rats: roles of adenosine deaminase and xanthine oxidase activities
Taofeek O. Usman, Emmanuel D. Areola, Olufunto O. Badmus, InKyeom Kim, Lawrence A. Olatunji
The Journal of Nutritional Biochemistry.2018; 62: 65. CrossRef
ADENOSINE DEAMINASE ACTIVITY IN TYPE 2 DIABETES MELLITUS
Farija Peruvankuzhiyil, Lavanya Madhavan, Manaloor George Joseraj
Journal of Evidence Based Medicine and Healthcare.2017; 4(5): 238. CrossRef
Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications
Maria Peleli, Mattias Carlstrom
Molecular Aspects of Medicine.2017; 55: 62. CrossRef
The Adenosinergic System in Diabetic Retinopathy
J. Vindeirinho, A. R. Santiago, C. Cavadas, A. F. Ambrósio, P. F. Santos
Journal of Diabetes Research.2016; 2016: 1. CrossRef
Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes
Alberto Nassi, Francesca Malorgio, Serena Tedesco, Andrea Cignarella, Rosa Maria Gaion
Cardiovascular Diabetology.2016;[Epub] CrossRef
Reduced adenosine A2a receptor–mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration
Patrik Persson, Peter Hansell, Fredrik Palm
Kidney International.2015; 87(1): 109. CrossRef
CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
Sang Ah Lee, Young Ree Kim, Eun Jin Yang, Eun-Jeong Kwon, Sun Hyung Kim, Sung Ha Kang, Doek Bae Park, Byung-Chul Oh, Jinseok Kim, Sang Taek Heo, Gwanpyo Koh, Dae Ho Lee
The Journal of Clinical Endocrinology & Metabolism.2013; 98(6): 2553. CrossRef
Raised Serum Adenosine Deaminase Level in Nonobese Type 2 Diabetes Mellitus
Vineet Kumar Khemka, Debajit Bagchi, Arindam Ghosh, Oishimaya Sen, Aritri Bir, Sasanka Chakrabarti, Anindita Banerjee, R. E. Felberbaum, V. Sánchez-Margalet, S. Ulisse
The Scientific World Journal.2013;[Epub] CrossRef
Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
Yochai Birnbaum, Alexander C. Castillo, Jinqiao Qian, Shukuan Ling, Hongmei Ye, Jose R. Perez-Polo, Mandeep Bajaj, Yumei Ye
Cardiovascular Drugs and Therapy.2012; 26(6): 445. CrossRef
Serum Adenosine deaminase activity in type 2 Diabetes Mellitus patients
M. N. Vanitha Gowda, K. C. Vasudha, S. Reshma, K. J. Sujatha
International Journal of Diabetes in Developing Countries.2012; 32(3): 176. CrossRef
Cyclic AMP and PKA: How can a Lot of Good Come from the Potentially Bad?
Barbara Huisamen
Cardiovascular Drugs and Therapy.2012; 26(6): 435. CrossRef
Gadd45α: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction
Ning Wang, Chao Yang, Fang Xie, Lihua Sun, Xiaolin Su, Ying Wang, Ran Wei, Rong Zhang, Xia Li, Baofeng Yang, Jing Ai, Rajesh Gopalrao Katare
PLoS ONE.2012; 7(12): e49077. CrossRef
The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes
Joanne S. J. Chia, Jennifer L. McRae, Peter J. Cowan, Karen M. Dwyer
Journal of Biomedicine and Biotechnology.2012; 2012: 1. CrossRef

Author index